Immune checkpoint therapy in melanoma Review uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunomodulation
  • Melanoma
  • Molecular Targeted Therapy

abstract

  • Checkpoint-blocking antibodies have transformed cancer therapy, and the treatment of patients with metastatic melanoma has led the revolution. Herein, we review the current clinical data supporting the use of checkpoint-blocking antibodies in the treatment of melanoma and highlight outstanding clinical questions and unmet clinical needs.

publication date

  • May 25, 2016

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/PPO.0000000000000183

PubMed ID

  • 27111901

Additional Document Info

start page

  • 73

end page

  • 80

volume

  • 22

number

  • 2